Crowdonomics
SunState Laboratories

Reg CF · Preferred Stock · Nov 2021

ClosedReached targetReg CFPreferred Equity
via WeFunderView campaign
Raised
$166K / $3M max
6% of ceiling · target hit day 6
Investors
183
$906.8 avg
Post-money valuation
$12.2M
pre-money + amount raised

Raised over time

Cumulative raisedInvestors
$166K$83K$0
171860
Nov 10, 2021 · openedFeb 18, 2022 · last reading
Target ($100K) hit — Nov 16, 2021, day 6Deadline Apr 30, 2022 — 71 days out

Left axis: cumulative dollars raised. Right axis: cumulative investors. Live figures via WeFunder; investor counts may lag the platform by up to a day.

Financials disclosed in this offering

FY2019–FY2020 · hover for source
$20K
−$54K
FY2019
$166K
−$376K
FY2020
RevenueNet income
Metric
FY2019
FY2020
Income statement
Revenue
$20,354
$165,911
Cost of goods sold
$13,173
$87,208
Gross margin
35%
47%
Net income
-$53,544
-$375,621
Taxes paid
$0
$0
Balance sheet
Cash
$7,952
$493,028
Accounts receivable
$0
$17,179
Total assets
$85,716
$689,425
Short-term debt
$18,606
$26,309
Long-term debt
$0
$0
Total liabilities
$18,606
$26,309
Other
Headcount
—
4

The fiscal years the issuer disclosed in this offering’s filing, as filed. Full history on the company page.

Deal terms

Pre-money$12M ($10M early bird)
Post-money$12.2M
Price / share$12.63
Shares offered9,497

Perks

First $500K investors will invest at $10.53 per share and a $10M pre-money valuationfirst $500K

Offering details

Target$100,003
Max$2,999,989
Min investment$100
OpenedNov 10, 2021
DeadlineApr 30, 2022
ClosedFeb 18, 2022
Days active100

Links & provenance

Source: Manual
0001670254-21-001188

About this data. Raised amounts and investor counts come from the platform listing and may lag or be restated; SEC-reported totals can differ until the next Form 1-Z/C-U. Post-money valuation is computed as pre-money plus amount raised and is shown once the round closes — it is not a traded price. Financial statements are as reported by the issuer. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.